IGE Therapeutics Inc
Pharmaceutical ManufacturingCalifornia, United States11-50 Employees
IGE Therapeutics, Inc. operates in the pharmaceutical manufacturing sector with a focus on allergy treatments. The company aims to develop a universal IgE allergy vaccine intended to reduce the severity of allergic syndromes and potentially influence the natural progression of allergic asthma and rhinitis, addressing unmet needs in immune-related allergic conditions. Its target market includes individuals affected by allergic diseases, with a clear emphasis on improving disease outcomes and quality of life through a novel therapeutic approach. Based in San Diego, California, the company is a small to mid-sized organization focused on innovation in allergy therapy within the broader pharmaceutical landscape. A recent development includes continued work on its vaccine approach, reflecting ongoing efforts to advance its product candidate in the field of allergy management.